We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-2.03%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.68B
AUM Growth
-$7.95M
Cap. Flow
+$55.2M
Cap. Flow %
3.28%
Top 10 Hldgs %
17.16%
Holding
515
New
107
Increased
139
Reduced
156
Closed
69

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$46.2M
2
RACE icon
Ferrari
RACE
+$26.2M
3
DINO icon
HF Sinclair
DINO
+$10.4M
4
PFE icon
Pfizer
PFE
+$10.1M
5
FTI icon
TechnipFMC
FTI
+$9.95M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$51.3M
2
MTD icon
Mettler-Toledo International
MTD
+$37.2M
3
ADSK icon
Autodesk
ADSK
+$26M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$25.6M
5
TRMB icon
Trimble
TRMB
+$12.5M

Sector Composition

Rank Sector Weight
1 Healthcare 24.95%
2 Technology 20.52%
3 Consumer Discretionary 16.46%
4 Industrials 8.03%
5 Financials 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSKA
326
DELISTED
Heska Corp
HSKA
$581K 0.03%
8,204
-7
-0.1% -$526
CIGI icon
327
Colliers International
CIGI
$5.2B
$578K 0.03%
7,700
-10
-0.1% -$709
NPKI
328
NPK International
NPKI
$1.18B
$578K 0.03%
75,900
– –
CGBD icon
329
Carlyle Secured Lending
CGBD
$713M
$570K 0.03%
39,600
– –
GOLF icon
330
Acushnet Holdings
GOLF
$6.07B
$565K 0.03%
21,400
-55
-0.3% -$1.44K
GPRK icon
331
GeoPark
GPRK
$622M
$560K 0.03%
+30,522
New +$545K
CYTK icon
332
Cytokinetics
CYTK
$11B
$558K 0.03%
49,000
-7,122
-13% -$89.4K
CMTL icon
333
Comtech Telecommunications
CMTL
$52.4M
$550K 0.03%
16,926
+26
+0.2% +$741
MGNI icon
334
Magnite
MGNI
$2.77B
$540K 0.03%
+61,999
New +$543K
VECO icon
335
Veeco
VECO
$2.89B
$528K 0.03%
+45,200
New +$509K
LJPC
336
DELISTED
La Jolla Pharmaceutical Company
LJPC
$524K 0.03%
+59,542
New +$563K
CEVA icon
337
CEVA Inc
CEVA
$971M
$523K 0.03%
17,500
-2,300
-12% -$67K
SM icon
338
SM Energy
SM
$7.45B
$515K 0.03%
+53,100
New +$541K
NBHC icon
339
National Bank Holdings
NBHC
$1.91B
$511K 0.03%
+14,949
New +$520K
COLL icon
340
Collegium Pharmaceutical
COLL
$1.16B
$502K 0.03%
43,700
-11,100
-20% -$127K
RDWR icon
341
Radware
RDWR
$1.24B
$497K 0.03%
20,500
– –
ACLS icon
342
Axcelis
ACLS
$3.83B
$483K 0.03%
+28,275
New +$452K
BANC icon
343
Banc of California
BANC
$3.22B
$481K 0.03%
34,000
-22,300
-40% -$322K
NPTN
344
DELISTED
NEOPHOTONICS CORP
NPTN
$470K 0.03%
77,161
-53,739
-41% -$302K
GFF icon
345
Griffon
GFF
$4.24B
$468K 0.03%
22,300
– –
ATRA icon
346
Atara Biotherapeutics
ATRA
$71.4M
$459K 0.03%
+1,300
New +$485K
SAFT icon
347
Safety Insurance
SAFT
$1.51B
$447K 0.03%
4,408
+1,108
+34% +$108K
LPG icon
348
Dorian LPG
LPG
$1.87B
$440K 0.03%
42,500
+22,871
+117% +$224K
EFC
349
Ellington Financial
EFC
$1.69B
$435K 0.03%
+24,048
New +$427K
NETI
350
DELISTED
Eneti Inc.
NETI
$426K 0.03%
7,546
-685
-8% -$38.4K
12 13
14
15 16

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
WAS
Wesleyan Assurance Society Birmingham, United Kingdom $1.69B AUM 28.38% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PDT Partners's Q3 2019 Portfolio in Review

As of Q3 2019, PDT Partners held 515 positions worth $1.68B, down 0.47% from $1.69B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

PDT Partners deployed $55.2M of net new capital in Q3 2019, opening 107 new positions and adding to 139 existing holdings. Its largest new stake was Linde: 238,663 shares worth $46.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $51.3M trimmed.

  • PDT Partners's largest Q3 2019 buy was Linde: 238,663 shares worth $46.2M.
  • PDT Partners added most to Ferrari in Q3 2019, an estimated $26.2M increase.
  • PDT Partners's biggest Q3 2019 reduction was AbbVie, cutting an estimated $51.3M.
  • PDT Partners fully exited Mettler-Toledo International in Q3 2019, selling an estimated $37.2M.
  • PDT Partners's ten largest holdings make up 17% of its $1.68B portfolio in Q3 2019.
  • PDT Partners opened 107 new positions and closed 69 in Q3 2019.
  • PDT Partners's portfolio value fell 0.47% quarter-over-quarter to $1.68B.

Based on PDT Partners's 13F filing for Q3 2019, filed 14 Nov 2019.